Investor Overview

Satsuma Pharmaceuticals Investor Relations

Corporate Presentation

Download

 

Recent News
Feb 18, 2020

South San Francisco, CA, February 18, 2020 – Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today announced that John Kollins, President and Chief...

Jan 28, 2020

South San Francisco, CA, January 28, 2020 – Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA), a clinical-stage biopharmaceutical company, today announced that Phase 1 trial results detailing...

Nov 26, 2019

South San Francisco, CA, November 26, 2019 – Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA) a clinical-stage biopharmaceutical company, today announced that John Kollins, Satsuma President and...

Stock Info
NASDAQSTSA